Naganuma Mitsuki, Nishida Masayuki, Kuramochi Kouji, Sugawara Fumio, Yoshida Hiromi, Mizushina Yoshiyuki
Department of Applied Biological Science, Tokyo University of Science, Noda, Chiba 278-8510, Japan.
Bioorg Med Chem. 2008 Mar 15;16(6):2939-44. doi: 10.1016/j.bmc.2007.12.044. Epub 2007 Dec 25.
Talaroflavone (1) and 1-deoxyrubralactone (2) are natural compounds isolated from cultures of a fungal strain derived from sea algae, and their structures were determined by spectroscopic analyses. Compound 2 is a novel rubralactone derivative, 6-hydroxy-8-methoxy-1-methyl-1,2,3a,9b-tetrahydrocyclopenta[c]isochromene-3,5-dione. These compounds selectively inhibited the activities of families X and Y of eukaryotic DNA polymerases (pols), and compound 2 was a stronger inhibitor than compound 1. The IC(50) values of compound 2 on rat pol beta, which is a pol of family X, and human pol kappa, which is a pol of family Y, were 11.9 and 59.8 microM, respectively. On the other hand, compounds 1 and 2 did not influence the activities of the other families of eukaryotic pols, such as family A (i.e., pol gamma) and family B (i.e., pols alpha, delta, and epsilon), and showed no effect even on the activities of plant pols alpha and beta, prokaryotic pols, and other DNA metabolic enzymes, such as calf primase of pol alpha, human immunodeficiency virus type-1 (HIV-1) reverse transcriptase, human telomerase, T7 RNA polymerase, mouse IMP dehydrogenase (type II), human topoisomerase I and II, T4 polynucleotide kinase, and bovine deoxyribonuclease I. This is the first report about the selective inhibitors of families X and Y of eukaryotic pols.
塔拉黄酮(1)和1-脱氧红曲内酯(2)是从一种源自海藻的真菌菌株培养物中分离得到的天然化合物,其结构通过光谱分析确定。化合物2是一种新型红曲内酯衍生物,即6-羟基-8-甲氧基-1-甲基-1,2,3a,9b-四氢环戊[c]异苯并二氢吡喃-3,5-二酮。这些化合物选择性地抑制真核生物DNA聚合酶(Pol)X和Y家族的活性,且化合物2是比化合物1更强的抑制剂。化合物2对属于X家族的大鼠Polβ和属于Y家族的人Polκ的IC50值分别为11.9和59.8微摩尔。另一方面,化合物1和2不影响真核生物Pol其他家族的活性,如A家族(即Polγ)和B家族(即Polα、δ和ε),甚至对植物Polα和β、原核生物Pol以及其他DNA代谢酶的活性也无影响,这些酶包括Polα的小牛引发酶、人类免疫缺陷病毒1型(HIV-1)逆转录酶、人类端粒酶、T7 RNA聚合酶、小鼠IMP脱氢酶(II型)、人类拓扑异构酶I和II、T4多核苷酸激酶以及牛脱氧核糖核酸酶I。这是关于真核生物Pol X和Y家族选择性抑制剂的首次报道。